Semaglutide 20mg – Buy Semaglutide Peptide

Semaglutide 20mg is a high-purity GLP-1 receptor agonist peptide provided strictly for laboratory research use. As an analog of human GLP-1 (glucagon-like peptide-1), Semaglutide offers investigators a well-characterized compound for exploring incretin signaling pathways, receptor binding, and metabolic mechanisms in controlled experimental settings. This 20mg lyophilized peptide (≥99% purity) is intended solely for non-clinical, non-human studies.

• Third-Party Lab Verified
• Mannitol-Free Preparation
• Fast, Discreet Shipping

Why Choose Semaglutide 20mg?

🔬 GLP-1 Pathway Research

Selective Incretin Agonist: Semaglutide interacts with the GLP-1 receptor, a central node in incretin biology. Its activity has been widely examined in laboratory models, making it a valuable reference compound for researchers studying glucose-regulated signaling, receptor kinetics, and pancreatic islet physiology in vitro and in vivo (non-human).

🍽️ Satiety & Energy Balance Mechanisms

Investigated in Preclinical Studies: Laboratory research has frequently used GLP-1 analogues like Semaglutide to evaluate central and peripheral mechanisms related to satiety signaling, caloric intake, and nutrient handling. Semaglutide 20mg provides a consistent platform for studying these pathways in experimental systems without introducing confounding excipients.

🧪 High Purity & Stability

≥99% Purity, No Fillers: Produced at research-grade purity (HPLC-verified ≥99%), this preparation is excipient-free – no mannitol or glycine buffers. Each batch is supported by a Certificate of Analysis (COA) confirming identity and purity, giving laboratories confidence in reproducibility and data integrity.

⏱️ Long-Acting Analogue

Extended Profile: Structural modifications, including amino acid substitutions and a C-18 fatty acid chain, give Semaglutide an extended half-life compared to native GLP-1. This property makes it suitable for long-duration receptor activation studies, chronic exposure assays, and comparative evaluations against other incretin analogues under laboratory conditions.

What Is Semaglutide?

Semaglutide is a synthetic peptide analogue of the human incretin hormone GLP-1. It comprises 31 amino acids with modifications that enhance stability and albumin binding, prolonging its activity in experimental systems. As a GLP-1 receptor agonist, Semaglutide enables researchers to observe signaling cascades, receptor binding dynamics, and downstream metabolic pathways.

In research settings, Semaglutide is applied to explore:

• Incretin receptor biology – studying GLP-1 receptor activation, signaling efficiency, and cAMP-mediated pathways.
• Metabolic regulation mechanisms – investigating energy balance, nutrient sensing, and endocrine cross-talk in model systems.
• Comparative studies – benchmarking GLP-1 analogues against dual-agonist peptides (e.g., GLP-1/GIP) in controlled experimental frameworks.

Semaglutide has been the subject of extensive preclinical and clinical literature, giving researchers a robust reference point for experimental design. Note: The Semaglutide 20mg offered by BulkGLP is for laboratory use only and is not associated with, nor intended to substitute for, any approved therapeutic formulations.

Product Specifications

Peptide: Semaglutide (GLP-1 analog, modified human sequence)
Quantity: 20 mg per vial (lyophilized powder)
Purity: ≥99% (HPLC and Mass Spec verified)
Form: Lyophilized powder (acetate salt)
CAS Number: 910463-68-2
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉ (approx.)
Molecular Weight: ~4113.6 Da
Storage: Store at –20°C for long-term preservation. Protect from light and moisture. After reconstitution, keep the solution refrigerated (2–8°C) and use within 4–6 weeks.
Reconstitution: Reconstitute with sterile laboratory solvents suitable for peptide work. Swirl gently to dissolve. Do not shake vigorously.
Use: For research use only. Not for human consumption or therapeutic use.

Frequently Asked Questions

Q: How is Semaglutide different from Tirzepatide in research applications?

A: Both are incretin-related peptides but with different receptor profiles. Semaglutide is a GLP-1 selective agonist, while Tirzepatide is a dual GLP-1/GIP agonist. Researchers may select Semaglutide 20mg when isolating GLP-1 mediated effects or when comparing results against dual-agonist models.

Q: What are the primary research applications of Semaglutide?

A: Semaglutide is employed in laboratory studies focused on incretin biology, receptor pharmacology, and metabolic signaling mechanisms. All applications remain strictly non-clinical and investigational.

Q: Does Semaglutide 20mg require any special handling?

A: Semaglutide 20mg is supplied as a lyophilized powder. Before experiments, it can be reconstituted with suitable sterile solvents. Handle under appropriate laboratory conditions, avoid repeated freeze-thaw cycles, and aliquot as necessary for assay consistency.

Q: Is this the same Semaglutide used in medications?

A: Semaglutide 20mg is chemically identical to the GLP-1 analogue studied in scientific literature. However, this product is sold strictly for laboratory research use only. It is not produced, labeled, or authorized for human or veterinary use, and must not be used as a drug, supplement, or treatment.

Ready to Buy Semaglutide Peptide

Advance your research into incretin biology with Semaglutide 20mg from BulkGLP. With its verified purity, robust documentation, and consistent performance, this peptide is a dependable choice for laboratories investigating GLP-1 receptor pathways. Order now to secure high-quality research-grade material supported by rigorous testing and fast fulfillment.